Education
About Us
Working with TipRanks
Follow Us
PharmaTher Holdings Ltd (TSE:PHRM)
:PHRM
RESEARCH TOOLSreports
PHRM Stock Chart & Stats
Day’s Range― - ―
52-Week RangeC$0.16 - C$0.33
Previous CloseN/A
Volume18.00K
Average Volume (3M)59.95K
Market Cap
C$20.36M
Enterprise ValueC$3.78M
Total Cash (Recent Filing)C$1.55M
Total Debt (Recent Filing)C$0.00
Price to Earnings (P/E)―
Beta-0.26
Next Earnings
Sep 25, 2025EPS EstimateN/A
Last Dividend Ex-Date
Mar 30, 2023Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding88,519,066
10 Day Avg. Volume52,524
30 Day Avg. Volume59,950
Financial Highlights & Ratios
PEG Ratio-0.03
Price to Book (P/B)1.79
Price to Sales (P/S)0.00
P/FCF Ratio-3.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
PharmaTher Holdings Ltd News
PremiumCompany Announcements
PharmaTher Supports FDA’s New Program to Fast-Track Ketamine Therapies
PremiumCompany Announcements
PharmaTher’s Ketamine Drug Review Extended by FDA
PremiumCompany Announcements
PharmaTher Launches KetaVault™ to Propel Ketamine Innovation
PremiumCompany Announcements
PharmaTher Receives FDA Approval Goal Date for KetamineOptions Prices
Currently, No data available
---
Ownership Overview
17.61% Insiders
―
Mutual Funds
<0.01% Other Institutional Investors
82.39% Public Companies and
Individual Investors
PHRM FAQ
What was PharmaTher Holdings Ltd’s price range in the past 12 months?
PharmaTher Holdings Ltd lowest stock price was C$0.15 and its highest was C$0.33 in the past 12 months.
What is PharmaTher Holdings Ltd’s market cap?
PharmaTher Holdings Ltd’s market cap is C$20.36M.
When is PharmaTher Holdings Ltd’s upcoming earnings report date?
PharmaTher Holdings Ltd’s upcoming earnings report date is Sep 25, 2025 which is in 98 days.
How were PharmaTher Holdings Ltd’s earnings last quarter?
PharmaTher Holdings Ltd released its earnings results on Apr 28, 2025. The company reported -C$0.004 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.004.
Is PharmaTher Holdings Ltd overvalued?
According to Wall Street analysts PharmaTher Holdings Ltd’s price is currently Overvalued.
Does PharmaTher Holdings Ltd pay dividends?
PharmaTher Holdings Ltd pays a Notavailable dividend of C$0.027 which represents an annual dividend yield of N/A. See more information on PharmaTher Holdings Ltd dividends here
What is PharmaTher Holdings Ltd’s EPS estimate?
PharmaTher Holdings Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does PharmaTher Holdings Ltd have?
PharmaTher Holdings Ltd has 88,519,066 shares outstanding.
What happened to PharmaTher Holdings Ltd’s price movement after its last earnings report?
PharmaTher Holdings Ltd reported an EPS of -C$0.004 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of PharmaTher Holdings Ltd?
Currently, no hedge funds are holding shares in TSE:PHRM
Company Description
PharmaTher Holdings Ltd
PharmaTher Holdings Ltd (PHRM) is a clinical-stage biotech company focused on the research and development of psychedelic pharmaceuticals. The company's primary aim is to advance the clinical development of novel uses for psychedelic compounds, such as ketamine and psilocybin, in the treatment of mental health disorders, neurological diseases, and pain management. PharmaTher leverages its expertise in drug development and delivery systems to create innovative therapeutic solutions that address unmet medical needs.